Furthermore, staining of a TMA containing matched normal and prostate cancer tissue from 200 patients [26] showed GALNT7 levels were 1.8 fold higher in prostate cancer tissue compared to matched normal tissue from the same patient (p < 0.001) (Fig. 1E). This evidence concerns the gene GALNT7 and prostate carcinoma.